Copy to clipboard 
Proprio closed a $23 million Series A financing round. The computational imaging company is developing enhanced visualization systems for precise surgical execution. Proprio will use the financing to expand development teams, accelerate clinical and regulatory timelines, build commercialization capabilities and install the first Proprio systems. The company is presently running pilot programs in neuro and orthopedic surgery.
The Proprio system integrates robotics, artificial intelligence and computer vision to simplify surgical workflow, improve procedural accuracy and reduce or eliminate exposure to radiation. Proprio Vision addresses issues of increased surgical productivity while improving surgical precision, two important factors for institutions facing backlogs of elective surgeries due to COVID-19, an upcoming shortage of 23,400 surgical specialists in the U.S. and physician burnout. The Proprio platform also creates new data sets to improve clinical capability over the long term.
Proprio surpasses visualization, allowing teams to see through obstructions, magnify in and out without losing depth of field or surface detail, align tools with pre-operative plans and collaborate with colleagues anywhere in the world.
“As a cerebrovascular neurosurgeon, I am interested in the potential to use Proprio’s system to navigate and digitize the entire surgical experience,” said Dr. Christopher Kellner, neurosurgeon at Mount Sinai in New York City. “It will let surgeons detect nuances that we wouldn’t have noticed otherwise – creating a new level of first-hand observation that would help us continuously learn and perfect our craft.”
Proprio closed a $23 million Series A financing round. The computational imaging company is developing enhanced visualization systems for precise surgical execution. Proprio will use the financing to expand development teams, accelerate clinical and regulatory timelines, build commercialization capabilities and install the first Proprio systems....
Proprio closed a $23 million Series A financing round. The computational imaging company is developing enhanced visualization systems for precise surgical execution. Proprio will use the financing to expand development teams, accelerate clinical and regulatory timelines, build commercialization capabilities and install the first Proprio systems. The company is presently running pilot programs in neuro and orthopedic surgery.
The Proprio system integrates robotics, artificial intelligence and computer vision to simplify surgical workflow, improve procedural accuracy and reduce or eliminate exposure to radiation. Proprio Vision addresses issues of increased surgical productivity while improving surgical precision, two important factors for institutions facing backlogs of elective surgeries due to COVID-19, an upcoming shortage of 23,400 surgical specialists in the U.S. and physician burnout. The Proprio platform also creates new data sets to improve clinical capability over the long term.
Proprio surpasses visualization, allowing teams to see through obstructions, magnify in and out without losing depth of field or surface detail, align tools with pre-operative plans and collaborate with colleagues anywhere in the world.
“As a cerebrovascular neurosurgeon, I am interested in the potential to use Proprio’s system to navigate and digitize the entire surgical experience,” said Dr. Christopher Kellner, neurosurgeon at Mount Sinai in New York City. “It will let surgeons detect nuances that we wouldn’t have noticed otherwise – creating a new level of first-hand observation that would help us continuously learn and perfect our craft.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
